Skip to main content
. 2011 Apr 19;26(12):3980–3986. doi: 10.1093/ndt/gfr160

Table 2.

Frequently reported AEs (>5% in either group)

C.E.R.A., n = 150 (%) Darbepoetin alfa, n = 155 (%)
Hypertension 24 (16.0) 37 (23.9)
Renal impairment 9 (6.0) 16 (10.3)
Hyperkalaemia 13 (8.7) 8 (5.2)
Upper respiratory tract infection 9 (6.0) 11 (7.1)
Constipation 5 (3.3) 12 (7.7)
Diarrhoea 10 (6.7) 6 (3.9)
Urinary tract infection 6 (4.0) 8 (5.2)
Hypotension 5 (3.3) 8 (5.2)
Nasopharyngitis 5 (3.3) 8 (5.2)
Pneumonia 2 (1.3) 8 (5.2)